Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

MERCK KGAA : Buy rating from Independant Research

share with twitter share with LinkedIn share with facebook
09/18/2020 | 06:43am EDT

Already positive, the research from Independant Research and its analyst Tobias Gottschalt still consider the stock as a Buy opportunity. The target price has been revised upwards and is now set at EUR 138, compared with EUR 124 previously.

© MarketScreener with dpa-AFX Analyser 2020

share with twitter share with LinkedIn share with facebook
All news about MERCK KGAA
10/30MERCK KGAA : Sell rating from Goldman Sachs
MD
10/29MERCK : Mammoth Biosciences Partner to Produce, Scale Up Covid-19 Test
DJ
10/28MERCK KGAA : Kepler Cheuvreux remains its Buy rating
MD
10/28MERCK : to Invest EUR20 Million in Display-Technology Production
DJ
10/27MERCK : MAVENCLAD® (cladribine tablets) is available through public drug plans f..
AQ
10/27MERCK KGAA : JP Morgan remains Neutral
MD
10/21MERCK KGAA : Morgan Stanley reaffirms its Neutral rating
MD
10/21MERCK KGAA : Bernstein reiterates its Neutral rating
MD
10/16Physiomics Wins Contracts With Existing Customers
DJ
10/15MERCK : Global Head of R&D for Healthcare to Retire
DJ
More news
Financials
Sales 2020 17 300 M 20 146 M 20 146 M
Net income 2020 1 724 M 2 008 M 2 008 M
Net Debt 2020 10 781 M 12 554 M 12 554 M
P/E ratio 2020 30,5x
Yield 2020 1,07%
Capitalization 55 282 M 64 424 M 64 376 M
EV / Sales 2020 3,82x
EV / Sales 2021 3,53x
Nbr of Employees 57 523
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 126,95 €
Last Close Price 127,15 €
Spread / Highest target 18,0%
Spread / Average Target -0,15%
Spread / Lowest Target -20,6%
EPS Revisions
Managers
NameTitle
Stefan Oschmann Chairman-Executive Board & CEO
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Christian Raabe Independent Member-Supervisory Board
Edeltraud Glänzer Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA20.69%64 424
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD108.70%20 679
KYOWA KIRIN CO., LTD.0.66%13 303
BETTA PHARMACEUTICALS CO., LTD.62.97%6 450
YUHAN CORPORATION25.79%3 282
RECIPHARM AB (PUBL)9.32%1 627